medical marijuana

Stinky Pete

Stinky Pete has been released! Stinky Pete is 1/2 Snowtracks, 1/4 Vortex, 1/8 Dynamite, and 1/8 OG Kush causing an intense body high. Testing up at 25% this strain has and Earthy, manly smell, with an herbal nutty flavor with notes of cheese.

This strain is named after Pete Bergeman, who was well known throughout the Hood River Marijuana industry and passed away doing what he loved. Pete did a lot from Otis Gardens and he left his mark by building many custom work areas in the garden. He ran a tight crew and was well liked.

When Otis popped some seeds from their private breeding stock they discovered a large, powerful, and smelly 9 bladed plant. Pete died around the same time this strain was born so it is named in memory of him.

Come down and try this potent strain!

Gaia Medbar gets DOPE

On Feb 1, 2016 Dope Magazine published an article about Gaia Medbars, a delicious chocolate bar which we happen to carry. If you haven't tried one, come down quick to get a taste!

"Edible enthusiasts unite in celebration as talented culinary artisans and visionaries shake the shackles of cannabis prohibition and create progressive new dishes using THC infused ingredients. Accomplished chefs Megan Endres and Zack Derck have teamed up with DOPE Magazine to repurpose and give new life to the handcrafted cannabinoid-laden chocolate Gaia Medbar."

Read the full article HERE.

Trust your Bud- Gorge Greenery is Pesticide Free!

While this article was released in June earlier this year, it's come to our attention that many medical patients and recreational users alike are unaware of the serious risk of pesticides in Cannabis flower and products. Here at Gorge Greenery, we carry Clean Green Certified gardens and send everything out to OG Analytical (one of the trusted labs used in this study), for the most comprehensive pesticide screening capabilities in Oregon to ensure clean product every time.

"Dab Society Dutch Treat, a potent cannabis extract sold to medical marijuana patients, sailed through state-mandated pesticide testing. The results were printed on the label, backed by an official report. Workers at a Southeast Portland dispensary were happy to share the lab certificate. All you had to do was ask.

But, in fact, two laboratories commissioned by The Oregonian/OregonLive found pesticides in the same sample of Dutch Treat at levels above what the state allows.

It wasn’t an isolated case.

A combination of lax state rules, inconsistent lab practices and inaccurate test results has allowed pesticide-laced products to enter the medical marijuana market, The Oregonian/OregonLive has found.

Marijuana that fails a pesticide screen is not supposed to be sold to patients. But two other cannabis products in addition to Dutch Treat also tested above acceptable levels for pesticides.

The Oregonian/OregonLive shopped at Oregon dispensaries, bought cannabis that had passed pesticide tests and sent the samples to independent labs for further screening. Two labs performed the analysis: OG Analytical, a marijuana testing lab in Eugene, and Pacific Agricultural Laboratory, a Portland lab that specializes in detecting pesticides on foods and agricultural commodities. Both confirmed in blind testing the presence of pesticides that should have triggered red flags from previous labs."

Read the full article from The Oregonian/OregonLive HERE.

Senate Approved Funding Bill Allowing Medical Marijuana for Veterans

Just in time for Veterans Day, the Senate passed the Fiscal Year 2016 Military Construction and Veteran Affairs (MilCon-VA) Appropriations Bill, which will include a stipulation for the first time ever to allow doctors in the Veterans Administration to recommend medical marijuana to their patients in states where it is legal.

This is not the first time that Congress has tried to gain medical cannabis access for veterans. Representative Earl Blumenauer (D-OR) of the House of Representatives has introduced the Veterans Equal Access Act not once, but twice in the past two years, only for the bill to stall in the Subcommittee on Health. This time, the bipartisan amendment was introduced by Senator Jeff Merkley (D-OR) and Senator Steve Daines (R-MT) and was included in the Senate Appropriations committee this past May.

Having passed through the Senate Appropriations Committee with an 18-12 vote, the funding bill will now be included and negotiated as part of a more comprehensive omnibus spending bill to determine federal funding for the next fiscal year. A version of the Daines-Merkley amendment was included as an extension of the much-lauded CARERS Act, and although the bill has generated bipartisan interest and gained numerous sponsors from both sides of the aisle, Congress has not taken action towards passing it.

Allowing veterans access to medical marijuana has proved to be controversial in the past, despite evidence that cannabis can help alleviate many severe symptoms of Post-Traumatic Stress Disorder (PTSD), which affects nearly 31 percent of Vietnam veterans and as much as 11 percent of veterans of the Gulf War and war efforts in Afghanistan.

Veterans, we salute your service, and we are grateful to see Congress offering a token of gratitude for the soldiers who risk their lives for our peace of mind.

PopNaturals special!

Buy any 2 cartridges and get a free battery! 

(While Suplies last)

Columbia Gorge Collective

Northernberry and Big Wreck from Columbia Gorge Collective are now in! Grown locally by one of our own Gorge Greenery Girls! Both are indicas, come down and grab some while supplies last!

Grand Opening and 21+ Rec Party!

Come to our party!

Live local music and catering from Boda’s Kitchen begins at 5! Specials Include:   *sign up for our mailing list and get a free pre roll
*buy a PAX2 and get a free grinder
*drawing every half hour for hats, shirts, socks, glassware, grinders, and gift certificates
*buy 7grams and get $5 off any size CVault
Looking forward to seeing you there!
21+ and OMMP card holders welcome

Facebook Link is here –>Facebook Event and
Google+ Link is here –> Google Calendar, Gmail, Google+                                                                                                                           Find us on WordPress here!

See you then! :-)                                                                                                                            


 

National Alzheimer's Day

Today is National Alzheimer’s Day, a day dedicated to the pursuit of medical research that could one day better the lives of millions of people who are affected by this disease. Here are the top 5 ways Cannabis helps these patients.

1. THC Slows Buildup of Neural Plaques

One of the characterizing pathological markers of Alzheimer’s is the buildup of amyloid plaques, a toxic aggregation of peptides in the neural tissue. This 2008 study published in Molecular Pharmaceutics found that THC slowed this amyloid β-peptide (Aβ) overgrowth, a discovery that was again observed in a 2014 study that appeared in Journal of Alzheimer’s Disease. The earlier authors even found a low dose of THC to be “a considerably more effective inhibitor of AChE-induced Aβ deposition than the approved drugs for Alzheimer's disease treatment, donepezil and tacrine, which reduced Aβ aggregation by only 22% and 7%, respectively, at twice the concentration used in our studies.”

 

2. Cannabis Fights Inflammation

Another contributor to the development of Alzheimer’s is inflammation around these amyloid plaques. A 2006 report published in Neuroscience analyzed the role of the endocannabinoid system (ECS) in Alzheimer’s, as activation of CB1 receptor sites had an anti-inflammatory effect. Other research cited in a 2012 review reiterated its importance; one study found that mice bred without CB1 receptors experienced faster cognitive degeneration. The connection between the ECS and neurodegenerative diseases has yet to be developed in human trials, but the premise of this preliminary research alone is encouraging.

 

3. CBD Could Prevent Cell Death

THC isn’t the only compound cannabis has to offer for Alzheimer’s research; the non-psychoactive cannabidiol – better known as CBD – has also hinted at its benefits in preventing cell death. In 2004, researchers noted CBD’s neuroprotective, anti-oxidative, and anti-apoptotic properties, thus reducing neurotoxicity caused by amyloid buildup. These phenomena were again reviewed in a 2009 report that explored promising avenues in cannabinoid therapy, including that which involves a combination of THC and CBD. Noting the synergistic potential of cannabis constituents like CBD and THC, the researchers concluded with cautious optimism:

“The great therapeutic value of CBD, either given alone or in association with THC, derives from the consideration that it represents a rare, if not unique, compound that is capable of affording neuroprotection by the combination of different types of properties (e.g., anti-glutamatergic effects, anti-inflammatory action, and antioxidant effects) that almost cover all spectra of neurotoxic mechanisms that operate in neurodegenerative disorders (excitotoxicity, inflammatory events, oxidative injury, etc.).”

 

4. Cannabinoids Stimulate Cell Growth

So in addition to cannabis’ antioxidant, anti-inflammatory, and neuroprotective attributes, it would appear that cannabinoids may also play a role in the growth of neural tissue in the hippocampus – the area of the brain associated with memory. This mechanism known as “neurogenesis” was explored and discussed in a 2011 study, as well as in a 2007 report that observed cannabinoids “supporting the brain's intrinsic repair mechanisms.”

 

5. Staving Off Other Alzheimer’s Symptoms

One of the more compelling arguments for medical marijuana is its ability to alleviate other symptoms associated with Alzheimer’s, allowing patients to live happier and more functional lives. From appetite stimulation and weight control to motor functioning and agitation reduction, the improved quality of life that cannabis may offer these patients should be enough to warrant a rescheduling of these versatile cannabinoids.

Looking back at decades of research supporting cannabis’ therapeutic benefits in not only Alzheimer’s, but in cancer, pain, epilepsy, stress disorders, sleep disorders, MS, HIV/AIDS, glaucoma, fibromyalgia, gastrointestinal disorders, arthritis, anorexia, diabetes, spasticity, it’s utterly incomprehensible to see cannabis still ranked as a Schedule 1 substance among the likes of heroin.


Cheers to all of the scientists out there making this research happen despite political obstacles and pitfalls.